Actively Recruiting
Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan
Led by Khushal Khan Khattak Univeristy, Karak, Pakistan · Updated on 2024-05-30
200
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This Randomized Controlled Trial will check the efficacy of Eye Movement Desensitization \& Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan
CONDITIONS
Official Title
Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 60 years
- Patients must be able to move their hands and eyes and perform basic movements
- Patients must be conscious and able to recover consciousness
- Patients must meet the basic screening criteria for PTSD and have PTSD as a main problem
- Patients without severe intellectual impairments allowing communication
You will not qualify if you...
- Patients younger than 15 years or older than 60 years
- Patients unable to move their hands and eyes or perform basic movements
- Patients unconscious for long periods and unable to regain consciousness
- Patients who do not meet PTSD screening criteria or for whom PTSD is not the main problem
- Patients with severe intellectual impairments that impair communication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Anwar Khan
Karak, Pakistan, 27200
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here